e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Mechanisms of epithelial cell activation II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Activation of proteolytic mechanisms in response to inflammatory stimuli: a possible role in the development of the aleolocapillary barrier damage
H. Szabo, Z. Novak, E. Szatmari, K. Wejksza, A. Farkas, I. A. Krizbai (Szeged, Hungary)
Source:
Annual Congress 2003 - Mechanisms of epithelial cell activation II
Session:
Mechanisms of epithelial cell activation II
Session type:
Thematic Poster Session
Number:
2903
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Szabo, Z. Novak, E. Szatmari, K. Wejksza, A. Farkas, I. A. Krizbai (Szeged, Hungary). Activation of proteolytic mechanisms in response to inflammatory stimuli: a possible role in the development of the aleolocapillary barrier damage. Eur Respir J 2003; 22: Suppl. 45, 2903
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Activity of an innate defence regulator peptide to alleviate airway inflammation is mitigated by disruption of its central hydrophobic region
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
iNOS inhibition modulates lung tissue inflammation via oxidative stress pathway activation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
Dysregulation of the “inflammatory reflex” with abnormal neurohumoral activation may contribute to proinflammatory activity driving the progression of COPD
Source: Eur Respir J, 51 (6) 1800806; 10.1183/13993003.00806-2018
Year: 2018
Oral presentation: Inhibition of innate host defense in airway epithelial cells by cigarette smoke in an in vitro infection model caused by suppression of NF-kB activation
Source: Lung Science Conference 2010 - Biology of gene-environment interactions in the lung
Year: 2010
The influence nitrosative stress and toxic metabolites NO on formation of a phenotype of the immune answer at airway inflammation
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010
Gut microbial modulation attenuates emphysema development by suppressing inflammation and apoptosis
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
LSC 2010 Abstract: Inhibition of innate host defense in airway epithelial cells by cigarette smoke in an
in vitro
infection model caused by suppression of NF-κB activation
Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease
Year: 2010
Signalling and transcriptional regulation in inflammatory and immune cells: importance in lung biology and disease
Source: Eur Respir J 2005; 26: 762-763
Year: 2005
Dysregulation of host defence peptides by environmental challenge: Can we mitigate the pathophysiology?
Source: International Congress 2019 – Infections, the microbiome and host defence peptides in the development and progression of asthma
Year: 2019
WNT-4 regulates pro-inflammatory responses driven by epithelial-mesenchymal cross-talk
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
cPLA2alpha plays a role in neutrophilic inflammatory response in mice induced by tobacco smoke exposure
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
Modulation of oxidative stress pathway by arginase inhibition: Evaluation in an animal model of chronic pulmonary inflammation
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
The role of innate immune cells in inflammation
Source: International Congress 2015 – Resolving inflammation
Year: 2015
Extracellular vesicles are key intercellular mediators in the development of immune dysfunction to allergens in the airway
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Role of altered immune response in CF and implication for antiinflammatory therapies
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
Disease-specific inflammatory environments induce different anti-inflammatory MSC actions that play critical roles in mitigating lung injury
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Fas activation impairs the alveolar epithelial function in mice by mechanisms involving apoptosis
Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury
Year: 2011
Do the inflammatory and oxidative basal statuses modulate the functional capacity response after a pulmonary rehabilitation program?
Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases
Year: 2017
Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B.
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept